Eli Lilly (LLY) Share-based Compensation (2009 - 2026)
Eli Lilly (LLY) posted Share-based Compensation of $201 million for Q2 2026, up 8.6% from $185 million a year earlier and up 24.8% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Share-based Compensation (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Eli Lilly was $649 million, up 5.6% year-over-year; for FY2025, it was $626 million, down 3.1% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 15.2% (FY2020 to FY2025).
- In prior years, Eli Lilly's Share-based Compensation was $646 million in FY2024 (+2.7%), $629 million in FY2023 (+69.5%), $371.1 million in FY2022 (+8.3%) and $342.8 million in FY2021 (+11.3%).
- The Q2 2026 figure stands as the highest quarterly Share-based Compensation since Q2 2024.
- On a year-over-year basis, Share-based Compensation increased in four of the last eight quarters, with an average decline of 1.7%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2023, with growth of 153.3%; the weakest was Q3 2024, with a decline of 38.2%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $161 million (Q1 2026), $136.1 million (Q4 2025) and $150.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Vertex Pharmaceuticals | 128.38 Bn | 100.39 Bn | 2.84 Bn | 170.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 201.00 Mn |
| Mar 31, 2026 | 161.00 Mn |
| Dec 31, 2025 | 136.10 Mn |
| Sep 30, 2025 | 150.90 Mn |
| Jun 30, 2025 | 185.00 Mn |
| Mar 31, 2025 | 154.00 Mn |
| Dec 31, 2024 | 142.30 Mn |
| Sep 30, 2024 | 133.20 Mn |
| Jun 30, 2024 | 211.10 Mn |
| Mar 31, 2024 | 159.40 Mn |
| Dec 31, 2023 | 120.70 Mn |
| Sep 30, 2023 | 215.60 Mn |
| Jun 30, 2023 | 161.50 Mn |
| Mar 31, 2023 | 131.20 Mn |
| Dec 31, 2022 | 92.90 Mn |
| Sep 30, 2022 | 85.10 Mn |
| Jun 30, 2022 | 92.10 Mn |
| Mar 31, 2022 | 101.00 Mn |
| Dec 31, 2021 | 75.30 Mn |
| Sep 30, 2021 | 90.10 Mn |
API Access
Eli Lilly Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();